Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-29

Clinical Trial Update: TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders [Phase 3]

View source ↗

Summary

Phase 3 interventional study TAP-GRIN for GRIN-related neurodevelopmental disorders is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TAP-GRIN

Snippet

Sponsor: Meyer Children's Hospital IRCCS | Conditions: GRIN-related Disorders, GRIN1 | Phase 3 | Status: RECRUITING